0K3W Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 5.89 USD 0.17%

Market Cap: $249.5m

M	Myriad Genetics Inc LSE:0K3W	US
	PSP Swiss Property AG XETRA:P7S	CH
C	Cencora Inc XMUN:ABG	US
O	Osmosun SA PAR:ALWTR	FR
	Alimentation Couche-Tard Inc TSX:ATD	CA
T	Timken Co XBER:TKH	US
N	North American Construction Group Ltd F:N5Z	CA
S	Sanofi SA LSE:0O59	FR
I	Ionis Pharmaceuticals Inc XBER:ISI	US
	Hong Kong and China Gas Co Ltd HKEX:3	HK
S	Six Flags Entertainment Corp F:6FE	US
	QuickLogic Corp NASDAQ:QUIK	US
H	Hershey Co F:HSY	US
B	Barrick Gold Corp XBER:ABR	CA
	IDEX Corp NYSE:IEX	US
M	Metso Outotec Corp F:M6Q	FI
	Dingdong (Cayman) Ltd NYSE:DDL	CN
I	International Seaways Inc XBER:IS5	US
	Lumen Technologies Inc F:CYTH	US

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

68% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-26% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-36% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-17% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC